APLS logo

Apellis Pharmaceuticals (APLS) Current Assets

Annual Current Assets

$766.33 M
+$46.81 M+6.51%

31 December 2023

APLS Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$833.90 M
-$26.08 M-3.03%

30 September 2024

APLS Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

APLS Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.5%+4.7%
3 y3 years-16.4%+75.4%
5 y5 years+278.6%+84.8%

APLS Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-16.4%+6.5%-24.5%+75.4%
5 y5 years-16.4%+278.6%-24.5%+123.5%
alltimeall time-16.4%>+9999.0%-24.5%+6044.4%

Apellis Pharmaceuticals Current Assets History

DateAnnualQuarterly
Sept 2024
-
$833.90 M(-3.0%)
June 2024
-
$859.97 M(+6.0%)
Mar 2024
-
$811.43 M(+5.9%)
Dec 2023
$22.40 M(-45.0%)
$766.33 M(-3.8%)
Sept 2023
-
$796.77 M(-10.7%)
June 2023
-
$892.69 M(-6.5%)
Mar 2023
-
$954.25 M(+32.6%)
Dec 2022
$40.69 M(-29.5%)
$719.52 M(-13.5%)
Sept 2022
-
$831.94 M(-13.3%)
June 2022
-
$959.97 M(-13.0%)
Mar 2022
-
$1.10 B(+34.0%)
Dec 2021
$57.72 M(+33.1%)
$824.05 M(+73.3%)
Sept 2021
-
$475.43 M(-27.4%)
June 2021
-
$655.13 M(-15.3%)
Mar 2021
-
$773.63 M(-15.7%)
Dec 2020
$43.38 M
$917.19 M(+23.6%)
Sept 2020
-
$742.35 M(-13.1%)
June 2020
-
$853.83 M(+27.0%)
DateAnnualQuarterly
Mar 2020
-
$672.41 M(+80.2%)
Dec 2019
$16.15 M(+1375.8%)
$373.10 M(-17.3%)
Sept 2019
-
$451.19 M(+46.3%)
June 2019
-
$308.41 M(-0.7%)
Mar 2019
-
$310.53 M(+53.4%)
Dec 2018
$1.09 M(+841.7%)
$202.44 M(-15.3%)
Sept 2018
-
$238.93 M(-10.4%)
June 2018
-
$266.70 M(+63.5%)
Mar 2018
-
$163.09 M(-10.4%)
Dec 2017
$116.20 K(+80.2%)
$182.02 M(+856.3%)
Sept 2017
-
$19.03 M(-66.4%)
June 2017
-
$56.57 M(+106.7%)
Dec 2016
$64.50 K(-51.6%)
$27.37 M(-28.1%)
Dec 2015
$133.30 K(+126.3%)
$38.04 M(+180.3%)
Sept 2015
-
$13.57 M(-18.8%)
June 2015
-
$16.71 M(+17.3%)
Dec 2014
$58.90 K(+547.3%)
$14.25 M
Dec 2013
$9100.00
-

FAQ

  • What is Apellis Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual current assets year-on-year change?
  • What is Apellis Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly current assets year-on-year change?

What is Apellis Pharmaceuticals annual total current assets?

The current annual current assets of APLS is $766.33 M

What is the all time high annual current assets for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual total current assets is $917.19 M

What is Apellis Pharmaceuticals annual current assets year-on-year change?

Over the past year, APLS annual total current assets has changed by +$46.81 M (+6.51%)

What is Apellis Pharmaceuticals quarterly total current assets?

The current quarterly current assets of APLS is $833.90 M

What is the all time high quarterly current assets for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly total current assets is $1.10 B

What is Apellis Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, APLS quarterly total current assets has changed by +$37.13 M (+4.66%)